Celcuity share price logo

Celcuity

NASDAQ: CELC

Mid Cap

$96.77

+0.57

(+0.59%)

Live

as on

Celcuity Stock Performance

as on September 4, 2026 at 2:06 am IST

  • Day's Low

    Day's High

    $95.81
    $97.85
    downward going graph

    0.99%

    Downside

    1.12%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $44.42
    $151.02
    downward going graph

    54.10%

    Downside

    56.06%

    Upside

    downward going graph

Celcuity share price movements today

Previous Close
$96.20
Open
$97.70
Volume
151.4K
Market Cap
$4.3B
Day's Low - High
$95.81 - $97.85
52 Week Low - High
$44.42 - $151.02

Celcuity Historical Returns

1 Month Return
+ 6.48 %
3 Month Return
+ 0.61 %
1 Year Return
+ 71.67 %
3 Year Return
+ 833.81 %
5 Year Return
+ 307.17 %

Celcuity Stock Fundamentals & Key Indicators

Check Celcuity market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.3B

EPS (TTM)

-4.29

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-21.44

Industry PE ratio

-13.558214285714286

PEG Ratio

1.0262304843436751

EBITDA

-185.3M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-350.78%

Celcuity Stock Valuation

Track how Celcuity P/E has moved over time to understand its valuation trends.

Celcuity in the last 5 years

  • Overview

  • Trends

Lowest (-26.39x)

December 31, 2025

Today (-26.39x)

December 31, 2025

Industry (-13.56x)

December 31, 2025

Highest (-4.62x)

March 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -26.39x

Celcuity vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Celcuity with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$4.3B307.17%-21.440.00%NA
BUY$44.6B614.61%NA0.00%NA
BUY$137.9B174.9%31.9286.04%NA
BUY$61.6B-61.21%-7.98-12.57%NA
BUY$82.3B21.91%19.984.86%0.44%

Stock Returns calculator for Celcuity Stock including INR - Dollar returns

The Celcuity stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Celcuity investment value today

Current value as on today

₹1,93,737

Returns

₹93,737

(+93.74%)

Returns from Celcuity Stock

₹80,608 (+80.61%)

Dollar Impact

₹13,128 (+13.13%)

Analyst Recommendation on Celcuity Stock

Based on 10 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 10 analysts, 100% of analysts recommend a 'BUY' rating for Celcuity. Average target price of $161.09

Celcuity Share Price Target

Get share price movements and forecasts by analysts on Celcuity.

What analysts predicted

39.93%UPSIDE

Target Price

$161.09

Current Price

$96.77

Analyzed by

10 Analysts

Target

$161.09

Celcuity target price $161.09, a slight upside of 39.93% compared to current price of $96.77. According to 10 analysts rating.

Indian Investors' Interest in Celcuity Stock

Search interest for Celcuity Stock has decreased by -54% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-54% versus previous 30 day period

Celcuity Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
-
-
-
-
0
-
-
0
-
Operating Income
-19
-22
-24
-30
-36
-44
-42
-49
-50
-66
EBITDA
-17
-20
-21
-26
-33
-42
-39
-44
-46
-54
Interest Expense
1
1
2
3
3
3
17
6
6
5
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-18
-21
-23
-29
-36
-45
-43
-50
-52
-78
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-18
-21
-23
-29
-36
-45
-43
-50
-52
-78
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Celcuity Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Mar 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
-
-
-
-
-
-
-
Operating Income
-5
-7
-7
-9
-28
-39
-66
-113
-172
EBITDA
-5
-7
-7
-9
-28
-38
-58
-101
-159
Interest Expense
0
0
0
0
1
2
5
10
17
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-6
-7
-7
-9
-29
-40
-63
-111
-177
Income Tax Expense
0
-
-
-
-
-
-
-
-
Net Income
-6
-7
-7
-9
-29
-40
-63
-111
-177
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Celcuity Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-18
-21
-23
-29
-36
-45
-43
-50
-52
-78
Operating Cash Flow
-18
-17
-18
-20
-35
-36
-44
-36
-55
-55
Investing Cash Flow
-41
3
-106
1
24
65
-257
103
34
-330
Financing Cash Flow
64
14
123
0
5
0
330
24
0
422
Change in Cash
4
0
0
-17
-6
29
27
91
-20
36

Celcuity Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Mar 2025
Dec 2025
Net Income
-6
-7
-7
-9
-29
-40
-63
-111
-177
Operating Cash Flow
-4
-6
-5
-7
-20
-36
-53
-83
-153
Investing Cash Flow
-28
19
8
0
0
-144
-5
-63
-64
Financing Cash Flow
30
0
0
0
93
120
64
138
360
Change in Cash
-3
13
2
-7
72
-59
6
-8
143

Mutual Funds that own Celcuity Stock

Check out the Mutual Funds with significant holdings in Celcuity.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.551684%
1737907
T. ROWE PRICE HEALTH SCIENCES FUND, INC.
1.085181%
531000
Fidelity Salem Street Trust
0.77627%
379844
Fidelity Concord Street Trust
0.756686%
370261
Artisan Partners Funds Inc.
0.578855%
283245

Global Institutional Holdings in Celcuity

Funds
Holdings
Felix Baker
16.18%
Joseph Edelman
6.53%
Vanguard
4.39%
iShares
3%
James E. Flynn
2.97%

Celcuity News & Key Events

  • img

    Today's Timeline - 04 May

    Mon, 04:35 PM

    -

    Celcuity shares surged nearly 18% after positive Phase 3 trial results for gedatolisib in advanced breast cancer.

Insights on Celcuity

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, CELC stock has moved up by 77.5%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, CELC has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 527.1% return, outperforming this stock by 449.6%

About Celcuity

Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic targets of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2 to treat patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) or HR+/HER2-, advanced or metastatic breast cancer (ABC), and patients with metastatic castration resistant prostate cancer (mCRPC). The company had a license agreement with Pfizer Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was incorporated in 2011 and is based in Minneapolis, Minnesota.
OrganisationCelcuity
Headquarters2800 Campus Drive, Minneapolis, MN, United States, 55441
IndustryBiotechnology
CEOMr. Brian F. Sullivan
E-voting on sharesClick here to vote

Key Management of Celcuity

Name

Title

Dr. Lance G. Laing Ph.D.

Co-Founder, Chief Science Officer, VP, Secretary & Director

Ms. Vicky Hahne CPA

Chief Financial Officer

Ms. Jodi Sievers

Head of Investor Relations & Corporate Communications

Mr. Brent Eilefson

General Counsel

Ms. Sheri Smith

Acting Head of Clinical Operations

Mr. Igor Gorbatchevsky M.D.

Chief Medical Officer

Mr. Eldon C. Mayer III, M.B.A.

Chief Commercial Officer

Mr. Brian F. Sullivan

Co-Founder, Chairman & CEO

FAQs

What is Celcuity share price today?

Celcuity share price today is $96.77 as on . Celcuity share today touched a day high of $97.85 and a low of $95.81.

What is the 52 week high and 52 week low for Celcuity share?

Celcuity share touched a 52 week high of $151.02 on and a 52 week low of $44.42 on . Celcuity stock price today i.e. is trending at $96.77,which is 35.92% down from its 52 week high and 117.85% up from its 52 week low.

What is Celcuity's market capitalisation today?

Celcuity market capitalisation is $0.00T as on .

How to invest in Celcuity Stock (CELC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Celcuity on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Celcuity Shares that will get you 0.0155 shares as per Celcuity share price of $96.77 per share as on September 3, 2026 at 8:36 pm IST.

What is the minimum amount required to buy Celcuity Stock (CELC) from India?

Indian investors can start investing in Celcuity (CELC) shares with as little as ₹94.475 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹944.75 in Celcuity stock (as per the Rupee-Dollar exchange rate as on ). Based on Celcuity share’s latest price of $96.77 as on September 3, 2026 at 8:36 pm IST, you will get 0.1033 shares of Celcuity. Learn more about fractional shares .

What are the returns that Celcuity has given to Indian investors in the last 5 years?

Celcuity stock has given 307.17% share price returns and 30.37% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?